House bill · H.R. 4101 (119th Congress)
Cancer Drug Parity Act of 2025
U.S. House of Representatives
Sponsor: Glenn Grothman (U.S. Representative, WI-6, Republican)
Following needs an Agora account. You will sign in first, then come back to this page.
From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data
Summary
Amends the Employee Retirement Income Security Act of 1974 to require group health plans and related coverage to apply cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing for anticancer medications administered by a health care provider.
AI summary. Not an official summary. How we handle summaries
Where it stands
Assigned to a committee for review.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
House Committee on Education and Workforce · U.S. House of Representatives
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Cosponsors
28
Cosponsors listed on Congress.gov, shown A to Z.
- Democratic23
- Republican5
This bill has cosponsors from more than one party.
Shown in neutral colors by design; Agora is non-partisan.
Related bills
As identified by Congress.gov.
Full history
- Jun 25, 2025
Introduced
Introduced in U.S. House
U.S. House
- Jun 24, 2025
Introduced
Introduced in House
U.S. House of Representatives
- Jun 24, 2025
In committee
Referred to the House Committee on Education and Workforce.
U.S. House
- Jun 24, 2025
Referred to committee
Referred to the House Committee on Education and Workforce.
U.S. House of Representatives
Read the record
- Read on Congress.gov (opens in a new tab) The official record on Congress.gov.